🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Gland Pharma Limited (BOM:543245)
India flag India · Delayed Price · Currency is INR
3,331.35
+40.30 (1.22%)
At close: Nov 20, 2026

Gland Pharma Statistics

Total Valuation

Gland Pharma has a market cap or net worth of INR 549.65 billion. The enterprise value is 517.75 billion.

Market Cap549.65B
Enterprise Value 517.75B

Important Dates

The last earnings date was Friday, November 6, 2026.

Earnings Date Nov 6, 2026
Ex-Dividend Date Aug 11, 2026

Share Statistics

Current Share Class 164.97M
Shares Outstanding n/a
Shares Change (YoY) +0.19%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) 0.00%
Owned by Institutions (%) 38.20%
Float 89.47M

Valuation Ratios

The trailing PE ratio is 44.49 and the forward PE ratio is 37.11.

PE Ratio 44.49
Forward PE 37.11
PS Ratio 7.77
PB Ratio 5.14
P/TBV Ratio 5.34
P/FCF Ratio 112.20
P/OCF Ratio 52.81
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.16, with an EV/FCF ratio of 105.69.

EV / Earnings 41.89
EV / Sales 7.32
EV / EBITDA 27.16
EV / EBIT 35.38
EV / FCF 105.69

Financial Position

The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.02.

Current Ratio 4.59
Quick Ratio 3.20
Debt / Equity 0.02
Debt / EBITDA 0.13
Debt / FCF 0.51
Interest Coverage 67.32

Financial Efficiency

Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 14.12%.

Return on Equity (ROE) 12.21%
Return on Assets (ROA) 7.40%
Return on Invested Capital (ROIC) 14.12%
Return on Capital Employed (ROCE) 13.05%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 16.33M
Profits Per Employee 2.85M
Employee Count4,332
Asset Turnover 0.57
Inventory Turnover 1.58

Taxes

In the past 12 months, Gland Pharma has paid 4.98 billion in taxes.

Income Tax 4.98B
Effective Tax Rate 28.72%

Stock Price Statistics

The stock price has increased by +88.02% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +88.02%
50-Day Moving Average 3,048.34
200-Day Moving Average 2,387.95
Relative Strength Index (RSI) 62.66
Average Volume (20 Days) 55,808

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Gland Pharma had revenue of INR 70.72 billion and earned 12.36 billion in profits. Earnings per share was 74.88.

Revenue70.72B
Gross Profit 41.99B
Operating Income 14.63B
Pretax Income 17.34B
Net Income 12.36B
EBITDA 18.89B
EBIT 14.63B
Earnings Per Share (EPS) 74.88
Full Income Statement

Balance Sheet

The company has 34.41 billion in cash and 2.51 billion in debt, with a net cash position of 31.90 billion.

Cash & Cash Equivalents 34.41B
Total Debt 2.51B
Net Cash 31.90B
Net Cash Per Share n/a
Equity (Book Value) 106.86B
Book Value Per Share 647.56
Working Capital 61.58B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.41 billion and capital expenditures -5.51 billion, giving a free cash flow of 4.90 billion.

Operating Cash Flow 10.41B
Capital Expenditures -5.51B
Depreciation & Amortization 4.25B
Net Borrowing -662.33M
Free Cash Flow 4.90B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.38%, with operating and profit margins of 20.69% and 17.48%.

Gross Margin 59.38%
Operating Margin 20.69%
Pretax Margin 24.52%
Profit Margin 17.48%
EBITDA Margin 26.71%
EBIT Margin 20.69%
FCF Margin 6.93%

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 0.60%.

Dividend Per Share 20.00
Dividend Yield 0.60%
Dividend Growth (YoY) 11.11%
Years of Dividend Growth n/a
Payout Ratio 26.69%
FCF Payout Ratio n/a
Buyback Yield -0.19%
Shareholder Yield 0.41%
Earnings Yield 2.25%
FCF Yield 0.89%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for Gland Pharma is 3,271.07, which is -1.81% lower than the current price. The consensus rating is "Buy".

Price Target 3,271.07
Price Target Difference -1.81%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (3Y) 15.80%
EPS Growth Forecast (3Y) 23.39%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7